跳至主要内容
临床试验/NCT05363566
NCT05363566Unknown不适用

Clinical Performance of the Baska MaskⓇ, the I-GelⓇ and the Self-Pressurized Air-QⓇ i

Cairo University1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2021年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
78
试验地点
1
主要终点
insertion time

研究概览

简要总结

The Baska mask (proact Medical Ltd, Northants, UK) is the latest addition to an era of supraglottic airway devices in clinical use. It is made of medical grade silicone; it has many advantages in its constructions over other LMA, a cuff less membranous bowl in which the saliva secretion collected. An inbuilt "tab" that allows to extend its angulation for straightforward negotiation of the oropharyngeal curve during placement

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Inclusion criteria
  • •Adult patients from 18 to 60 years of age.
  • •American Society of Anesthesiologists (ASA) physical status I and II
  • •Both genders
  • •Patients scheduled for elective surgeries lasting less than 2 hours under general anesthesia on spontaneous ventilation.
  • •El Ganzouri index Score ≥ 4
  • •Patients with BMI < 35 kg/m2

排除标准

  • •The patients who will be refusal or inability to give informed consent,
  • •ASA class III or IV
  • •El Ganzouri index Score < 4,
  • •Oropharyngeal pathology making a proper SAD fit unlikely as weak dentation, neck pathology
  • •Respiratory illness including upper respiratory infection or pneumonia within the six weeks preceding surgery
  • •Risk for gastric aspiration (e.g., hiatus hernia, gastro-oesophageal reflux disease or non-fasting status), expected duration of surgery longer than 2 h
  • •Contraindication to SGA use including morbid obesity (body mass index 35 kg m-1, history of obstructive sleep apnea)
  • •Any condition for which the primary anesthesia team deemed intubation with a tracheal tube to be necessary.

研究组 & 干预措施

group II

Active Comparator

will be inserted Single use supraglottic airway ( I-gel® ) (Intersurgical Ltd, Wokingham, Berkshire, UK)

干预措施: airway divice (Device)

group I

Active Comparator

will be inserted Single use supraglottic airway ( Baska mask® (proact Medical Ltd, Northants, UK)

干预措施: airway divice (Device)

group III (SP Air-Q) (n = 26)

Active Comparator

will be inserted Single use supraglottic airway (self-pressurized Air-Q intubating laryngeal airway (Air-Q SP®)) (Mercury Medical, Clearwater, FL, USA)

干预措施: airway divice (Device)

结局指标

主要结局

insertion time

时间窗: 1 hour

To determine the time taken for insertion of the device. (It will be calculated from the time of the mask will be taken away from the patient's face till the moment of the appearance of square wave capnography upstroke with the presence of sufficient ventilation) (second )

次要结局

  • Ease of device insertion(1 hours)
  • Oropharyngeal leak pressures(1 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Samir Wahdan

Principal Investigator

Cairo University

研究点 (1)

Loading locations...

相似试验